Gueripred Eye Drop contains Prednisolone 1% w/v, a potent corticosteroid used for its anti-inflammatory and immunosuppressive properties in ophthalmic conditions. It is indicated for the treatment of inflammatory eye disorders such as allergic conjunctivitis, anterior uveitis, keratitis, and post-operative inflammation following ocular surgery. Prednisolone acts by inhibiting the release of inflammatory mediators and suppressing the immune response, thereby reducing swelling, redness, and discomfort. Gueripred Eye Drop should be used under strict medical supervision due to the potential for adverse effects including increased intraocular pressure, delayed wound healing, and risk of secondary infections. It is contraindicated in viral, fungal, or mycobacterial eye infections and in patients with hypersensitivity to corticosteroids. Dosage and duration of treatment should be individualized based on the severity of the condition and patient response, with careful monitoring to avoid complications such as glaucoma or cataract formation. Patients are advised to avoid contamination of the dropper tip and to adhere to prescribed dosing schedules. Gueripred Eye Drop provides effective management of ocular inflammation when used appropriately, contributing to improved patient comfort and visual outcomes.